FDA Advisory Panel Votes Against Using MDMA Drug 'Ecstasy' a

FDA advisors cited concerns over clinical data, selection and expectation bias, and the safety risks of MDMA.

Related Keywords

United States , American , Michael Abrams , Maryann Amirshahi , Paul Holtzheimer , Kim Witczak , Brian Dempsey , Jonathan Alpert , Elizabeth Joniak , Drug Administration , Behavioral Sciences , American Psychiatric Association , Psychopharmacologic Drugs Advisory Committee , National Center , Department Of Psychiatry , Albert Einstein College Of Medicine , Multidisciplinary Association For Psychedelic Studies , National Institute On Drug Abuse , Public Citizen Health Research Group , Drug Enforcement Administration , Lycos , Would Involvethe , Lykos Therapeutics , Multidisciplinary Association , Psychedelic Studies , Public Benefit , New Drug Application , Nature Medicine , Trial Dataalthough , Lycos Therapeutic , Elizabeth Joniak Grant , National Institute , Drug Abuse , Human Psychopharmacology , Lykos Therapeutic , Wounded Warrior Project , Public Citizen , Health Research Group , Albert Einstein College ,